Transdermal estradiol
Transdermal estradiol has been studied in 1 paper since 2026: 1 observational study in people; 1 in the past year. The newest paper, Jun 25, 2026: “Transdermal versus oral hormone replacement therapy and bone mass density in Turner syndrome patients: a pilot study”.
1 paper studies it1 findingUpdated
See all 1 papers on transdermal estradiol
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country; 2 trials, 1 about aging.
“No significant differences were found between oral and transdermal estradiol therapy regarding absolute t-scores, t-score changes, or the proportion of patients with declining t-scores (all p > 0.05).”
- 1 lab in 1 country
- 2 trials, 1 about aging
- Humans1
What did studies of transdermal estradiol find?
1Studies of transdermal estradiol measured one outcome, bone mineral density T-score.
Bone mineral density T-score
no changein humans1
1 study
Bone mineral density T-score
no changein humans1
Transdermal estradiol was not clearly linked with bone mineral density T-score in humans (compared with oral estradiol).
“No significant differences were found between oral and transdermal estradiol therapy regarding absolute t-scores, t-score changes, or the proportion of patients with declining t-scores (all p > 0.05).”
Humanscompared with oral estradioltransdermallumbar spine and femoral neckfemales
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
Has transdermal estradiol been tested in people?
1 of 2 about agingYes: 1 observational study in people have been published.
About aging
Kronos Early Estrogen Prevention Study (KEEPS)
Phase 4Status unknown
Trial sponsors
Kronos Longevity Research Institute
1 trialPhase 4728 people
1 trialPhase 475 people